Home Cart 0 Sign in  
X

[ CAS No. 91271-82-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 91271-82-8
Chemical Structure| 91271-82-8
Chemical Structure| 91271-82-8
Structure of 91271-82-8 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 91271-82-8 ]

Related Doc. of [ 91271-82-8 ]

Alternatived Products of [ 91271-82-8 ]
Product Citations

Product Details of [ 91271-82-8 ]

CAS No. :91271-82-8 MDL No. :MFCD06655814
Formula : C12H18N2O Boiling Point : -
Linear Structure Formula :- InChI Key :NMFAEZHWSZZJOA-UHFFFAOYSA-N
M.W : 206.28 Pubchem ID :4962390
Synonyms :

Calculated chemistry of [ 91271-82-8 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.5
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 64.09
TPSA : 38.49 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.19
Log Po/w (XLOGP3) : 0.44
Log Po/w (WLOGP) : 0.29
Log Po/w (MLOGP) : 0.86
Log Po/w (SILICOS-IT) : 1.89
Consensus Log Po/w : 1.14

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.49
Solubility : 6.61 mg/ml ; 0.0321 mol/l
Class : Very soluble
Log S (Ali) : -0.82
Solubility : 31.5 mg/ml ; 0.153 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.04
Solubility : 0.188 mg/ml ; 0.000912 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.55

Safety of [ 91271-82-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 91271-82-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 91271-82-8 ]

[ 91271-82-8 ] Synthesis Path-Downstream   1~7

  • 1
  • [ 91271-82-8 ]
  • [ 1028338-59-1 ]
  • [ 1028336-86-8 ]
YieldReaction ConditionsOperation in experiment
23.3% With sodium t-butanolate;tris-(dibenzylideneacetone)dipalladium(0); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; In ISOPROPYLAMIDE; at 80℃; for 1h; Example 92: 4-Chloro-6-(2-morpholin-4-ylmethyI-benzyIamino)-2H-phthalazin-l- one; A mixture 6-bromo-4-chloro-2H-phthalazin-l-one (150 mg, 0.58 mmol), 2- mophiholin-4-ylmethyl-benzylamine (132 mg, 0.64 mmol), Pd2(dba)3 (53 mg, 0.058 <n="87"/>mmol), rac-BINAP (132 mg, 0.17 mmol) and NaOt-Bu (140 mg, 1.45 mmol) in DMA (6 mL) was heated at 8O0C for Ih. The mixture was allowed to cool, diluted with EtOAc (25 mL) and washed with water (25 mL). The organic layer was dried over anhydrous sodium sulfate and concentrated. Chromatography on silica (EtOAc/hexanes) yielded the title compound. 4-Chloro-6-(2-morpholin-4-ylmethyl-benzylamino)-2H-phthalazin- 1 - one: 52 mg (23.3%): m/z (M+eta)=385. 1H-NMR (DMSO-J6) delta: 12.27 (s,lH), 7.85 (d,lH), 7.51 (m,lH), 7.22 (m,2H), 7.16 (m,2H), 7.11 (dd,lH), 6.73 (s,lH), 4.55 (d,2H), 3.50 (m,6H), 2.23 (m, 4H).
  • 2
  • [ 91271-82-8 ]
  • [ 1217799-22-8 ]
  • [ 1217799-23-9 ]
YieldReaction ConditionsOperation in experiment
100% With acetic acid; In acetonitrile; at 70℃;Inert atmosphere; c) methyl [(4E)-1-(2-chloro-4-fluorophenyl)-4-(2-methoxy-1-[2-(morpholin-4-yl methyl)benzyl]amino}ethylidene)-5-oxo-4,5-dihydro-1H-pyrazol-3-yl]acetate (Compound of Formula (VIII), Scheme 2).; [Show Image] The mixture of the above obtained methyl [1-(2-chloro-4-fluorophenyl)-5-hydroxy-4-(methoxyacetyl)-1H-pyrazol-3-yl]acetate (Compound of Formula (X), 400mg, 1.12mmol, leq), and <strong>[91271-82-8]1-[2-(morpholin-4-ylmethyl)phenyl]methanamine</strong> (347 mg, 1.68 mmol, 1.5eq.) in Acetonitrile and acetic acid (101 mg, 1.68 mmol, *1.5eq.) were stirred at room temperature under nitrogen in toluene/NMP(10/1) or Acetonitrile (3 mL). The reaction mixture was heated up to 70C and the reaction monitored by HPLC. After 1 hour the reaction was mostly starting material, so more acetic acid was added (0.5 eq.), and then after a further 30 minutes yet more acetic acid was added (0.5 eq.). After a further 30 minutes, 0.5 eq. of <strong>[91271-82-8]1-[2-(morpholin-4-ylmethyl)phenyl]methanamine</strong> was added. The reaction was stirred for a further 30 minutes and worked up even though not all of the starting material had been consumed. The solvent was evaporated and the residue was dissolved in ethyl acetate (containing 0.1% triethylamine) and passed through a silica gel plug (6 cm diameter, by 2 cm) eluting with 250ml of the same solvent. Evaporation of the solvent gave gave the pure methyl[(4E)-1-(2-chloro-4-fluorophenyl)-4-(2-methoxy-1-[2-(morpholin-4-ylmethyl) benzyl]amino}ethylidene)-5-oxo-4,5-dihydro-1H-pyrazol-3-yl]acetate (149 mg, quantitative yield) which was used in the following step without further purification. MS(ESI+): 546.3; MS(ESI-): 544.5.
  • 3
  • [ 91271-82-8 ]
  • [ 1226789-23-6 ]
  • [ 1226788-97-1 ]
YieldReaction ConditionsOperation in experiment
73% In ethanol; at 20℃;Inert atmosphere; Microwave irradiation; Sealed tube; Heating; General procedure: To a solution containing S.I.-1 (0.20 g, 0.81 mmol) in 2 mL EtOH in a microwave reaction vial which could be sealed with a Teflon cap was added 4-amino-2,2,6,6-tetramethylpiperidine (0.13 g, 0.81 mmol). The tube was briefly flushed with an Argon stream (approximately 30 s) and sealed. The reaction was heated to 150 C for 1 hr in microwave and then allowed to cool to room temperature and stand for 12 hours, during which time a glassy solid formed. The solid was collected by filtration, washed with cold hexanes, and dried to give 140 mg (48%) of the product as a colorless crystalline solid.
  • 4
  • [ 91271-82-8 ]
  • [ 24277-39-2 ]
  • C17H25N3O4 [ No CAS ]
  • 5
  • [ 91271-82-8 ]
  • [ 24277-39-2 ]
  • C26H41N3O6 [ No CAS ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 120℃; for 0.5h;Microwave irradiation; General procedure: To a microwave vial containing a solution of Boc-L-glutamic acid tert-butyl ester (0.165 mmol, 1.0 equiv) and HATU (0.165 mmol, 1.0 equiv) in DMF (1.65 mL) was added the amine followed by DIPEA (57.5 muL, 2.0 equiv). The vial was sealed and heated under microwave irradiation for 30 min at 120 C. Upon completion, the reaction was partitioned between water and CH2Cl2, extracted 3× with CH2Cl2, dried over anhydrous Na2SO4, and concentrated under vacuum. Compounds were purified via reverse phase chromatography (5-95% acetonitrile/water) to afford the N-Boc-glutamylanilide-tert-butyl esters. The compounds were transferred to vials followed by the addition of 2.0 mL of 4.0 M HCl in dioxane. The reaction stirred at 40 C for 4 h. The reactions were concentrated under vacuum to afford the title compounds which were used without further purification.
  • 6
  • [ 91271-82-8 ]
  • (2SR,3SR)-2-(4-isopropoxyphenyl)-6-oxo-1-(4-(pyridin-4-ylmethyl)phenyl)-piperidine-3-carboxylic acid [ No CAS ]
  • (2SR,3SR)-2-(4-isopropoxyphenyl)-N-(2-(morpholinomethyl)benzyl)-6-oxo-1-(4-(pyridin-4-ylmethyl)phenyl)piperidine-3-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
30% General procedure: A solution of carboxylic acid (0.5 mmol) and HATU (0.55 mmol)in anhydrous DMF (2 mL) was stirred at ambient temperature for10 min. To this solution, DIPEA (0.6 mmol) and correspondingamine (0.54 mmol) were added successively and the mixture wasstirred for 18 h. After concentration under reduced pressure, thereaction mixture was treated with water (5 mL) and extracted withDCM (2 5 mL). After evaporation of the solvent, the residue wascrystallized from an appropriate solvent or subjected to columnchromatography on silica gel (DCM/MeOH) or preparative HPLC
  • 7
  • [ 91271-82-8 ]
  • C11H6FN4O2(1-)*Li(1+) [ No CAS ]
  • 5-amino-7-fluoro-N-(2-(morpholinomethyl)benzyl)imidazo[1,2-c]quinazoline-2-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
In N,N-dimethyl-formamide; at 20℃; General procedure: Additional amide analogs were prepared by adding 1.5 equivalents of an amine which will provide the desired substituents into a 1 dram vial (1.5 eq.) along with lithium 5-amino-7- methoxyimidazo[1,2-c]quinazoline-2-carboxylate (30 mg, 0.114 mmol) and a DMF solution (1.0 ml) solution of DIPEA (0.079 ml, 0.454 mmol), shaking the vial for 5 minutes in a Bohdan Miniblock Shaker and then adding 1-propanephosphonic acid cyclic anhydride (50% w/w in EtOAc, 64.7 mul, 0.109 mmol), and continuing to shake the vial at RT overnight. The completed reaction was quenched with 1.0 ml water and the organic layer separated by filtering through a Varian 2 ml Reservior Frit and a Whatman 0.45mum syringe filter to remove emulsion, followed by solvent removal using a Genevac. The crude residue was dissolved in 1.0 ml DMSO and purified by LC/MS.
Recommend Products
Same Skeleton Products

Technical Information

• 1,4-Addition of an Amine to a Conjugated Enone • 1,4-Addition of an Amine to a Conjugated Enone • Amides Can Be Converted into Aldehydes • Amine Synthesis from Nitriles • Amine Synthesis from Nitriles • Amines Convert Acyl Chlorides into Amides • Amines Convert Esters into Amides • Azide Reduction by LiAlH4 • Azide Reduction by LiAlH4 • Basicity of Amines • Buchwald-Hartwig C-N Bond and C-O Bond Formation Reactions • Chan-Lam Coupling Reaction • Chichibabin Reaction • Diazotization Reaction • DIBAL Attack Nitriles to Give Ketones • Enamine Formation • Formation of an Amide from an Amine and a Carboxylic Acid • Formation of an Amide from an Amine and a Carboxylic Acid • Hemiaminal Formation from Amines and Aldehydes or Ketones • Hemiaminal Formation from Amines and Aldehydes or Ketones • Hofmann Elimination • Hofmann Rearrangement • Hydride Reductions • Hydrolysis of Imines to Aldehydes and Ketones • Imine Formation from Amines and Aldehydes or Ketones • Leuckart-Wallach Reaction • Mannich Reaction • Methylation of Ammonia • Methylation of Ammonia • Nitrosation of Amines • Peptide Bond Formation with DCC • Petasis Reaction • Preparation of Amines • Preparation of LDA • Reactions of Amines • Reactions of Benzene and Substituted Benzenes • Reduction of an Amide to an Amine • Reduction of an Amide to an Amine • Reductive Amination • Reductive Amination • Ring Opening of Azacyclopropanes • Ring Opening of Azacyclopropanes • Ring Opening of Oxacyclobutanes • Specialized Acylation Reagents-Vilsmeier Reagent • Strecker Synthesis • Synthesis of 2-Amino Nitriles • Ugi Reaction
Historical Records

Related Functional Groups of
[ 91271-82-8 ]

Aryls

Chemical Structure| 2038-05-3

[ 2038-05-3 ]

N-Benzyl-2-morpholinoethanamine

Similarity: 0.95

Chemical Structure| 110859-47-7

[ 110859-47-7 ]

(4-Benzylmorpholin-2-yl)methanamine

Similarity: 0.90

Chemical Structure| 51013-67-3

[ 51013-67-3 ]

4-(Morpholinomethyl)aniline

Similarity: 0.88

Chemical Structure| 101376-25-4

[ 101376-25-4 ]

(S)-(4-Benzylmorpholin-3-yl)methanol

Similarity: 0.88

Chemical Structure| 110167-20-9

[ 110167-20-9 ]

N-Benzyl-3-(hydroxymethyl)morpholine

Similarity: 0.88

Amines

Chemical Structure| 2038-05-3

[ 2038-05-3 ]

N-Benzyl-2-morpholinoethanamine

Similarity: 0.95

Chemical Structure| 110859-47-7

[ 110859-47-7 ]

(4-Benzylmorpholin-2-yl)methanamine

Similarity: 0.90

Chemical Structure| 51013-67-3

[ 51013-67-3 ]

4-(Morpholinomethyl)aniline

Similarity: 0.88

Chemical Structure| 101-98-4

[ 101-98-4 ]

2-(Benzyl(methyl)amino)ethanol

Similarity: 0.87

Chemical Structure| 101-32-6

[ 101-32-6 ]

2,2-(Benzylimino)diethanol

Similarity: 0.87

Related Parent Nucleus of
[ 91271-82-8 ]

Aliphatic Heterocycles

Chemical Structure| 101376-26-5

[ 101376-26-5 ]

(R)-(4-Benzylmorpholin-3-yl)methanol

Similarity: 0.88

Chemical Structure| 51013-67-3

[ 51013-67-3 ]

4-(Morpholinomethyl)aniline

Similarity: 0.88

Chemical Structure| 101376-25-4

[ 101376-25-4 ]

(S)-(4-Benzylmorpholin-3-yl)methanol

Similarity: 0.88

Chemical Structure| 84761-04-6

[ 84761-04-6 ]

4-Benzyl-2,2-dimethylmorpholine

Similarity: 0.86

Chemical Structure| 943442-96-4

[ 943442-96-4 ]

(R)-(4-Benzylmorpholin-2-yl)methanol

Similarity: 0.86

Morpholines

Chemical Structure| 2038-05-3

[ 2038-05-3 ]

N-Benzyl-2-morpholinoethanamine

Similarity: 0.95

Chemical Structure| 110859-47-7

[ 110859-47-7 ]

(4-Benzylmorpholin-2-yl)methanamine

Similarity: 0.90

Chemical Structure| 51013-67-3

[ 51013-67-3 ]

4-(Morpholinomethyl)aniline

Similarity: 0.88

Chemical Structure| 101376-25-4

[ 101376-25-4 ]

(S)-(4-Benzylmorpholin-3-yl)methanol

Similarity: 0.88

Chemical Structure| 110167-20-9

[ 110167-20-9 ]

N-Benzyl-3-(hydroxymethyl)morpholine

Similarity: 0.88

; ;